Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology
Auckland-based Engender Technologies Limited operates in Biotechnology. Ownership is privately held; it publishes at engendertechnologies.com. It holds one address on record, all in New Zealand. The record counts 31 people. Tagged life sciences and biotechnology. Its latest round on record is Grant, US$22.3K. It is listed alongside six similar brands, mostly in Medical Equipment Manufacturing.
engendertechnologies.com LinkedIn
Engender technology is a next-generation livestock gender-sorting technology.
Engender was formed to solve the high value problem of gender selection in the dairy industry. Initially formed as a spin-out from University of Auckland, Engender's technology uses photonics to orient and sort livestock spermatozoa by gender at lower cost and lower impact than presently possible.
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
| Rounds | 5 |
|---|---|
| Axis | 2011 to 2026 |
| Grant · 15 Sep 2022 | US$ 22.3K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 31 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, New Zealand only. Primary: Kitchener Street, Auckland.
Five rounds. Latest 15 September 2022: grant, US$22,300, investor Callaghan Innovation.
Five tags on the brand's own list, among them life sciences and biotechnology.
4 profiles list Engender Technologies Limited as a peer — 56th percentile in Biotechnology. It lists ten peers of its own. Orbis Diagnostics and Luminoma Diagnostics Ltd list it back.